Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$93.3M |
| 2 |
Baxter International
BAX
|
+$41.7M |
| 3 |
Molina Healthcare
MOH
|
+$37.3M |
| 4 |
United Rentals
URI
|
+$36.8M |
| 5 |
Universal Health Services
UHS
|
+$23.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$525M |
| 2 |
HCA Healthcare
HCA
|
+$408M |
| 3 |
McKesson
MCK
|
+$303M |
| 4 |
Walt Disney
DIS
|
+$302M |
| 5 |
HOLX
Hologic
HOLX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 68.98% |
| 2 | Technology | 12.43% |
| 3 | Materials | 6.14% |
| 4 | Communication Services | 4.66% |
| 5 | Industrials | 3.82% |
Similar funds
Glenview Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Glenview Capital Management held 58 positions worth $3.68B, down 68% from $11.4B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Glenview Capital Management withdrew a net $5.27B in Q1 2020, closing 14 positions and reducing 26 holdings. Its most notable exit was Walt Disney, an estimated $302M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 61% a quarter earlier, followed by Technology and Materials.
Against the trend, Glenview Capital Management opened a new position in Boston Scientific worth $77.9M.
- Glenview Capital Management's largest Q1 2020 buy was Boston Scientific: 2,387,859 shares worth $77.9M.
- Glenview Capital Management added most to United Rentals in Q1 2020, an estimated $36.8M increase.
- Glenview Capital Management's biggest Q1 2020 reduction was Cigna, cutting an estimated $525M.
- Glenview Capital Management fully exited Walt Disney in Q1 2020, selling an estimated $302M.
- Glenview Capital Management's ten largest holdings make up 60% of its $3.68B portfolio in Q1 2020.
- Glenview Capital Management opened 8 new positions and closed 14 in Q1 2020.
- Glenview Capital Management's portfolio value fell 68% quarter-over-quarter to $3.68B.
Based on Glenview Capital Management's 13F filing for Q1 2020, filed 15 May 2020.